CF-MAB Publication
Publications
Storz, I. ; Schirmer, D. ; Wisskirchen, K. ; Feederle, R. ; Schmidt, O. ; Abken, H. ; Protzer, U. ; Burdach, S. ; Richter, G.H.S.
Therapeutic potential of GPR64 specific CAR T cells in pediatric sarcomas.Schlepckow, K. ; Kleinberger, G. ; Fukumori, A. ; Feederle, R. ; Lichtenthaler, S.F. ; Steiner, H. ; Haass, C.
An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function.Moschovakis, G.L. ; Bubke, A. ; Friedrichsen, M. ; Falk, C.S. ; Feederle, R. ; Förster, R.
T cell specific Cxcr5 deficiency prevents rheumatoid arthritis.Ayoubian, H. ; Fröhlich, T. ; Pogodski, D. ; Flatley, A. ; Kremmer, E. ; Schepers, A. ; Feederle, R. ; Arnold, G.J. ; Grässer, F.A.
Antibodies against the mono-methylated arginine-glycine repeat (MMA-RG) of the Epstein-Barr virus nuclear antigen 2 (EBNA2) identify potential cellular proteins targeted in viral transformation.Lehmer, C. ; Oeckl, P. ; Weishaupt, J.H. ; Volk, A.E. ; Diehl-Schmid, J. ; Schroeter, M.L. ; Lauer, M. ; Kornhuber, J. ; Levin, J. ; Fassbender, K. ; Landwehrmeyer, B. ; Schludi, M.H. ; Arzberger, T. ; Kremmer, E. ; Flatley, A. ; Feederle, R. ; Steinacker, P. ; Weydt, P. ; Ludolph, A.C. ; Edbauer, D. ; Otto, M.
Poly-GP in cerebrospinal fluid links C9orf72-associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD.Kleinberger, G. ; Brendel, M.D. ; Mracsko, E. ; Wefers, B. ; Groeneweg, L. ; Xiang, X. ; Focke, C. ; Deußing, M. ; Suárez-Calvet, M. ; Mazaheri, F. ; Parhizkar, S. ; Pettkus, N. ; Wurst, W. ; Feederle, R. ; Bartenstein, P. ; Mueggler, T. ; Arzberger, T. ; Knuesel, I. ; Rominger, A. ; Haass, C.
The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism.Zhou, Q. ; Lehmer, C. ; Michaelsen, M. ; Mori, K. ; Alterauge, D. ; Baumjohann, D. ; Schludi, M.H. ; Greiling, J. ; Farny, D. ; Flatley, A. ; Feederle, R. ; May, S. ; Schreiber, F. ; Arzberger, T. ; Kuhm, C. ; Klopstock, T. ; Hermann, A. ; Haass, C. ; Edbauer, D.
Antibodies inhibit transmission and aggregation of C9orf72 poly-GA dipeptide repeat proteins.Feederle, R. ; Schepers, A.
Antibodies specific for nucleic acid modifications.Bahrami, E. ; Witzel, M. ; Racek, T. ; Puchaka, J. ; Hollizeck, S. ; Greif-Kohistani, N. ; Kotlarz, D. ; Horny, H.-P. ; Feederle, R. ; Schmidt, H. ; Sherkat, R. ; Steinemann, D. ; Göhring, G. ; Schlegelbeger, B. ; Albert, M.H. ; Al-Herz, W. ; Klein, C.
Myb-like, SWIRM, and MPN domains 1 (MYSM1) deficiency: Genotoxic stress-associated bone marrow failure and developmental aberrations.Shumilov, A. ; Tsai, M.H. ; Schlosser, Y.T. ; Kratz, A.S. ; Bernhardt, K. ; Fink, S. ; Mizani, T. ; Lin, X. ; Jauch, A. ; Mautner, J. ; Kopp-Schneider, A. ; Feederle, R. ; Hoffmann, I. ; Delecluse, H.J.
Epstein-Barr virus particles induce centrosome amplification and chromosomal instability.Tsai, M.H. ; Lin, X. ; Shumilov, A. ; Bernhardt, K. ; Feederle, R. ; Poirey, R. ; Kopp-Schneider, A. ; Pereira, B. ; Almeida, R. ; Delecluse, H.J.
The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers.